Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in drug delivery systems, growing aging population, and rising prevalence of skin disorders.
The topical corticosteroids market is segmented as below:
By End-user
- Hospitals
- Dermatology clinics
- Pharmacies
- Others
By Type
- Prescription
- OTC
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the topical corticosteroids market covers the following areas:
- Topical corticosteroids market sizing
- Topical corticosteroids market forecast
- Topical corticosteroids market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global topical corticosteroids market: AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing adoption of generic drugs."
According to the report, one of the major drivers for this market is the advancements in drug delivery systems.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Galderma SA
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- LEO Pharma AS
- Merck and Co. Inc.
- Novartis AG
- Perrigo Co. Plc
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.